Identification of two novel mutations in three children with congenital factor VII deficiency.


Journal

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis
ISSN: 1473-5733
Titre abrégé: Blood Coagul Fibrinolysis
Pays: England
ID NLM: 9102551

Informations de publication

Date de publication:
01 Jul 2021
Historique:
pubmed: 16 2 2021
medline: 15 7 2021
entrez: 15 2 2021
Statut: ppublish

Résumé

Congenital factor VII deficiency (FVIID) is a rare F7 gene mutation causing bleeding disorder inherited in an autosomal recessive manner. In this study, we aimed to identify genetic defects and analyze their relationships with phenotype in three Chinese FVIID patients. The diagnosis of FVIID was made based on FVII coagulant activity (FVII:C) levels assessed through prothrombin time assay. Direct sequencing and protein modeling were performed to detect genetic mutations and the resulting protein expression. Patient 1, a 2-year-old girl, presented with mild bleeding and was found to have a FVII:C of 0.2% and a compound heterozygous F7 Cys389Gly/Cys115Arg mutation. Patient 2, a 7-year-old boy, consulted for moderate bleeding and was found to have a FVII:C of 0.8% and a compound heterozygous F7 Thr241Asn/Pro324Leu mutation. Patient 3, a 5-year-old boy who developed a mild bleeding after trauma was found to have a FVII:C of 1.8% and a compound heterozygous F7 Thr241Asn/ IVS5-2A>G mutation. We hereby report three congenital FVIID patients with FVII:C less than 2% and their respective F7 mutations, two of which (F7 Cys115Arg, Pro324Leu) are novel. The molecular model analysis of the two novel mutations F7 Cys115Arg and Pro324Leu respectively indicated impairment of the proper folding of epidermal growth factor 1 domain situated on F7 gene and impairment of the procoagulant function of FVII both leading to the congenital deficiency of FVII.

Identifiants

pubmed: 33587484
doi: 10.1097/MBC.0000000000001022
pii: 00001721-202107000-00007
pmc: PMC8279893
doi:

Substances chimiques

Factor VII 9001-25-6

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

340-343

Informations de copyright

Copyright © 2021 The Author(s). Published by Wolters Kluwer Health, Inc.

Références

Alexander B, Goldstein R, Landwehr G, Cook CD. Congenital SPCA deficiency: a hitherto unrecognized coagulation defect with hemorrhage rectified by serum and serum fractions. J Clin Invest 1951; 30:596–608.
Perry DJ. Factor VII deficiency. Br J Haematol 2002; 118:689–700.
Traivaree C, Monsereenusorn C, Meekaewkunchorn A, Laoyookhong P, Suwansingh S, Boonyawat B. Genotype and phenotype correlation in intracranial hemorrhage in neonatal factor VII deficiency among Thai children. Appl Clin Genet 2017; 10:37–41.
Sevenet PO, Kaczor DA, Depasse F. Factor VII deficiency: from basics to clinical laboratory diagnosis and patient management. Clin Appl Thromb Hemost 2017; 23:703–710.
Mashayekhi A, Shahbazi S, Omrani M. Functional and molecular characterization of C91S mutation in the second epidermal growth factor-like domain of factor VII. Iran J Biotechnol 2018; 16:e1813.
Herrmann FH, Wulff K, Auberger K, Aumann V, Bergmann F, Bergmann K, et al. Molecular biology and clinical manifestation of hereditary factor VII deficiency. Semin Thromb Hemost 2000; 26:393–400.
McVey JH, Boswell E, Mumford AD, Kemball-Cook G, Tuddenham EG. Factor VII deficiency and the FVII mutation database. Hum Mutat 2001; 17:3–17.
Yu T, Wang X, Ding Q, Fu Q, Dai J, Lu Y, et al. Using a minigene approach to characterize a novel splice site mutation in human F7 gene causing inherited factor VII deficiency in a Chinese pedigree. Haemophilia 2009; 15:1262–1266.
Millar DS, Kemball-Cook G, McVey JH, Tuddenham EG, Mumford AD, Attock GB, et al. Molecular analysis of the genotype–phenotype relationship in factor VII deficiency. Hum Genet 2000; 107:327–342.
Clarke BJ, Ofosu FA, Sridhara S, Bona RD, Rickles FR, Blajchman MA. The first epidermal growth factor domain of human coagulation factor VII is essential for binding with tissue factor. FEBS Lett 1992; 298:206–210.
Giansily-Blaizot M, Aguilar-Martinez P, Biron-Andreani C, Jeanjean P, Igual H, Schved JF. Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency. Eur J Hum Genet 2001; 9:105–112.
Leonard BJ, Chen Q, Blajchman MA, Ofosu FA, Sridhara S, Yang D, et al. Factor VII deficiency caused by a structural variant N57D of the first epidermal growth factor domain. Blood 1998; 91:142–148.
Mota L, Shetty S, Idicula-Thomas S, Ghosh K. Phenotypic and genotypic characterization of factor VII deficiency patients from Western India. Clin Chim Acta 2009; 409:106–111.
Bernardi F, Castaman G, Pinotti M, Ferraresi P, Di Iasio MG, Lunghi B, et al. Mutation pattern in clinically asymptomatic coagulation factor VII deficiency. Hum Mutat 1996; 8:108–115.

Auteurs

Kairong Liang (K)

Department of Pediatrics.

Lauriane Nikuze (L)

Department of Pediatrics.

Fuyong Zhang (F)

Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Zhengjing Lu (Z)

Department of Pediatrics.

Manlv Wei (M)

Department of Pediatrics.

Hongying Wei (H)

Department of Pediatrics.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH